Recent Finacing
Recent Raise
Great Basin Corporation develops sample-to-result chip-based molecular diagnostic platforms and multiplexed assays for infectious diseases, including an FDA-cleared C. difficile test, for use in CLIA-waived and moderately complex labs.
Focus Areas
Total Raised
Funding round